Does AZITHROMYCIN ANHYDROUS Cause Malignant neoplasm progression? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Malignant neoplasm progression have been filed in association with AZITHROMYCIN ANHYDROUS. This represents 0.1% of all adverse event reports for AZITHROMYCIN ANHYDROUS.
9
Reports of Malignant neoplasm progression with AZITHROMYCIN ANHYDROUS
0.1%
of all AZITHROMYCIN ANHYDROUS reports
8
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From AZITHROMYCIN ANHYDROUS?
Of the 9 reports, 8 (88.9%) resulted in death, 2 (22.2%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AZITHROMYCIN ANHYDROUS. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does AZITHROMYCIN ANHYDROUS Cause?
Off label use (3,288)
Drug ineffective (1,587)
Drug hypersensitivity (1,355)
Dyspnoea (947)
Nausea (727)
Diarrhoea (696)
Asthma (668)
Product use in unapproved indication (639)
Condition aggravated (621)
Cough (580)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which AZITHROMYCIN ANHYDROUS Alternatives Have Lower Malignant neoplasm progression Risk?
AZITHROMYCIN ANHYDROUS vs AZITHROMYCIN OR METHOTREXATE
AZITHROMYCIN ANHYDROUS vs AZOSEMIDE
AZITHROMYCIN ANHYDROUS vs AZTREONAM
AZITHROMYCIN ANHYDROUS vs AZTREONAM LYSINE
AZITHROMYCIN ANHYDROUS vs BACILLUS CALMETTE-GUERIN ANTIGEN, UNSPECIFIED SUBSTRAIN